Discovery of a Myeloid Cell Leukemia 1 (Mcl-1) Inhibitor That Demonstrates Potent In Vivo Activities in Mouse Models of Hematological and Solid Tumors.

MLA

Tarr, James C., et al. “Discovery of a Myeloid Cell Leukemia 1 (Mcl-1) Inhibitor That Demonstrates Potent In Vivo Activities in Mouse Models of Hematological and Solid Tumors.” Journal of Medicinal Chemistry, vol. 671, no. 6, Aug. 2024, pp. 14370–93. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.4c01188.

APA

Tarr, J. C., Salovich, J. M., Aichinger, M., Jeon, K., Veerasamy, N., Sensintaffar, J. L., Arnhof, H., Samwer, M., Christov, P. P., Kim, K., Wunberg, T., Schweifer, N., Trapani, F., Arnold, A., Martin, F., Zhao, B., Miriyala, N., Sgubin, D., Fogarty, S., & Moore, W. J. (2024). Discovery of a Myeloid Cell Leukemia 1 (Mcl-1) Inhibitor That Demonstrates Potent In Vivo Activities in Mouse Models of Hematological and Solid Tumors. Journal of Medicinal Chemistry, 671(6), 14370–14393. https://doi.org/10.1021/acs.jmedchem.4c01188

Chicago

Tarr, James C., James M. Salovich, Martin Aichinger, KyuOk Jeon, Nagarathanam Veerasamy, John L. Sensintaffar, Heribert Arnhof, et al. 2024. “Discovery of a Myeloid Cell Leukemia 1 (Mcl-1) Inhibitor That Demonstrates Potent In Vivo Activities in Mouse Models of Hematological and Solid Tumors.” Journal of Medicinal Chemistry 671 (6): 14370–93. doi:10.1021/acs.jmedchem.4c01188.